These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9923636)

  • 1. Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?
    Willenborg DO; Fordham SA; O'Brien NC; Cowden WB; Ramshaw IA
    Res Immunol; 1998; 149(9):804-10; discussion 849-50, 855-60. PubMed ID: 9923636
    [No Abstract]   [Full Text] [Related]  

  • 2. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
    Ruddle NH; Bergman CM; McGrath KM; Lingenheld EG; Grunnet ML; Padula SJ; Clark RB
    J Exp Med; 1990 Oct; 172(4):1193-200. PubMed ID: 2212948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity.
    Körner H; Sedgwick JD
    Immunol Cell Biol; 1996 Oct; 74(5):465-72. PubMed ID: 8912010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 5. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum.
    Jeffes EW; Ininns EK; Schmitz KL; Yamamoto RS; Dett CA; Granger GA
    Arthritis Rheum; 1989 Sep; 32(9):1148-52. PubMed ID: 2789046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis.
    Stevens DB; Gould KE; Swanborg RH
    J Neuroimmunol; 1994 Apr; 51(1):77-83. PubMed ID: 7512580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of TNFalpha and lymphotoxin in demyelinating disease.
    Lock C; Oksenberg J; Steinman L
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I121-8. PubMed ID: 10577988
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E; Tseveleki V; Chu SY; Tselios T; Karin M; Lassmann H; Szymkowski DE; Probert L
    Brain; 2011 Sep; 134(Pt 9):2722-35. PubMed ID: 21908876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling pathways of the TNF superfamily: a double-edged sword.
    Aggarwal BB
    Nat Rev Immunol; 2003 Sep; 3(9):745-56. PubMed ID: 12949498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.
    Frei K; Eugster HP; Bopst M; Constantinescu CS; Lavi E; Fontana A
    J Exp Med; 1997 Jun; 185(12):2177-82. PubMed ID: 9182689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis.
    Körner H; Goodsall AL; Lemckert FA; Scallon BJ; Ghrayeb J; Ford AL; Sedgwick JD
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11066-70. PubMed ID: 7479938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumor necrosis factor and lymphotoxin in lymphoid organ development.
    Ettinger R
    Curr Top Microbiol Immunol; 2000; 251():203-10. PubMed ID: 11036777
    [No Abstract]   [Full Text] [Related]  

  • 13. The Good, the Bad, or the Pretty: IL-17 Builds Lymphoid Tissues in the Brain.
    Becher B
    Immunity; 2015 Dec; 43(6):1033-4. PubMed ID: 26682978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxic cytokines in multiple sclerosis].
    Głabiński A
    Neurol Neurochir Pol; 1993; 27(6):869-75. PubMed ID: 8164782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF ligands and receptors in autoimmunity: an update.
    Mackay F; Kalled SL
    Curr Opin Immunol; 2002 Dec; 14(6):783-90. PubMed ID: 12413530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF and viruses: multiple interrelationships.
    Rubin BY
    Immunol Ser; 1992; 56():331-40. PubMed ID: 1550867
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
    Teramoto K; Baquerizo A; Imagawa DK; Seu P; Hart J; Dempsey RA; Terasaki PI; Kamada N; Busuttil RW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):602-3. PubMed ID: 1990621
    [No Abstract]   [Full Text] [Related]  

  • 18. Some misconceptions about understanding autoimmunity through experiments with knockouts.
    Steinman L
    J Exp Med; 1997 Jun; 185(12):2039-41. PubMed ID: 9221283
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.
    Powell MB; Mitchell D; Lederman J; Buckmeier J; Zamvil SS; Graham M; Ruddle NH; Steinman L
    Int Immunol; 1990; 2(6):539-44. PubMed ID: 1707660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta.
    Issazadeh S; Ljungdahl A; Höjeberg B; Mustafa M; Olsson T
    J Neuroimmunol; 1995 Sep; 61(2):205-12. PubMed ID: 7593556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.